Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease

Published on Dec 1, 2019in Scientific Reports4.011
· DOI :10.1038/s41598-019-39055-y
Boris Schmitz10
Estimated H-index: 10
Marcus E. Kleber51
Estimated H-index: 51
(FSU: University of Jena)
+ 8 AuthorsE. Brand31
Estimated H-index: 31
Chronic kidney disease (CKD) is an independent risk factor for onset and progression of coronary artery disease (CAD). Discovery of predisposing loci for kidney function in CAD patients was performed using a genome-wide association approach. Inclusion criteria were CAD with ≥50% stenosis (≥1 coronary artery) and a creatinine-based estimated glomerular filtration rate (eGFR) of 30–75 ml/min/1.73 m2. An association of rs139401390 located to a region 58.8 kb upstream of renalase (RNLS) with eGFR was detected in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study (n = 499, p = 7.88 × 10−9, mean eGFR 60.7 ml/min/1.73 m2). Direct genotyping of rs139401390A > G suggested increased eGFR by 12.0 ml/min/1.73 m2 per A allele (p = 0.000004). Genome-wide replication of rs139401390A > G in the Coronary Artery Disease and Renal Failure (CAD-REF) registry with a mean eGFR of 47.8 ml/min/1.73 m2 (n = 574, p = 0.033) was only nominally significant. Comparison of rs139401390 genotypes for risk of reduced kidney function in the overall LURIC study revealed higher adjusted odds ratios (OR) for eGFR <60 ml/min/1.73 m2 for CAD patients (n = 1992, OR = 2.36, p = 0.008, G/A + G/G vs A/A) compared to patients with/without CAD (n = 2908, OR = 1.97, p = 0.014, G/A + G/G vs A/A). No significant risk elevation was detected in patients without CAD (n = 948, p = 0.571). rs139401390 may affect kidney function in CAD patients with mild reduction in eGFR.
Figures & Tables
  • References (42)
  • Citations (0)
📖 Papers frequently viewed together
3 Citations
11 Authors (Hideki Horibe, ..., Yoshiji Yamada)
8 Citations
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Yu-Hsuan LiH-Index: 1
#2Wayne Huey-Herng Sheu (NYMU: National Yang-Ming University)H-Index: 46
Last. I-Te Lee (CSMU: Chung Shan Medical University)H-Index: 22
view all 7 authors...
Endothelin-1 (ET-1) is associated with endothelial dysfunction and vasoconstriction. Increased circulating ET-1 levels are associated with long-term cardiovascular mortality. Renalase, released from kidney, metabolizes catecholamines and regulates blood pressure. An increase in circulating renalase levels has been reported in patients with chronic kidney disease (CKD) and is associated with coronary artery disease (CAD). We hypothesized the existence of a synergistic effect of serum renalase lev...
2 CitationsSource
#2Holger ReineckeH-Index: 30
Last. E. BrandH-Index: 31
view all 11 authors...
Abstract Background Chronic kidney disease (CKD) and coronary artery disease (CAD) are strongly associated. CAD is the most frequent cause of cardiovascular death in patients with CKD. Methods The prospective observational nationwide multicenter C oronary A rtery D isease and RE nal F ailure (CAD-REF) Registry enrolled 3352 patients with angiographically documented CAD classified according to their baseline estimated glomerular filtration rate (eGFR) into 5 groups according to the K/DOQI-guideli...
2 CitationsSource
#1Yang Wang (Yale University)H-Index: 2
#2Robert Safirstein (Yale University)H-Index: 6
Last. Gary V. Desir (Yale University)H-Index: 29
view all 9 authors...
Renalase was discovered as a protein synthesized by the kidney and secreted in blood where it circulates at a concentration of approximately 3–5 μg/ml. Initial reports suggested that it functioned as an NAD(P)H oxidase and could oxidize catecholamines. Administration of renalase lowers blood pressure and heart rate and also protects cells and organs against ischaemic and toxic injury. Although renalase's protective effect was initially ascribed to its oxidase properties, a paradigm shift in our ...
6 CitationsSource
#1Mathias Gorski (University of Regensburg)H-Index: 21
#2Peter J. van der Most (UG: University of Groningen)H-Index: 20
Last. Christian FuchsbergerH-Index: 42
view all 126 authors...
HapMap imputed genome-wide association studies (GWAS) have revealed > 50 loci at which common variants with minor allele frequency > 5% are associated with kidney function. GWAS using more complete reference sets for imputation, such as those from The 1000 Genomes project, promise to identify novel loci that have been missed by previous efforts. To investigate the value of such a more complete variant catalog, we conducted a GWAS meta-analysis of kidney function based on the estimated glomerular...
43 CitationsSource
#1Mathias Gorski (University of Regensburg)H-Index: 21
#2Adrienne Tin (Johns Hopkins University)H-Index: 18
Last. Carsten A. Böger (University of Regensburg)H-Index: 20
view all 104 authors...
Genome-wide association studies (GWASs) have identified multiple loci associated with cross-sectional eGFR, but a systematic genetic analysis of kidney function decline over time is missing. Here we conducted a GWAS meta-analysis among 63,558 participants of European descent, initially from 16 cohorts with serial kidney function measurements within the CKDGen Consortium, followed by independent replication among additional participants from 13 cohorts. In stage 1 GWAS meta-analysis, single-nucle...
61 CitationsSource
Abstract Renalase was described in 2005 as a new flavoprotein expressed mainly in the kidney that functions as a flavin adenine dinucleotide (FAD)- and nicotinamide adenine dinucleotide (NADH)-dependent amine oxidase. In contrast to other monoamine oxidases, renalase can be secreted into both plasma and urine where it has been suggested to metabolise catecholamines and contribute to blood pressure control. Renalase was first reported to be undetectable in patients with chronic kidney disease (CK...
6 CitationsSource
#1Ling Wang (Yale University)H-Index: 7
#2Heino Velazquez (Yale University)H-Index: 29
Last. Gary V. Desir (Yale University)H-Index: 29
view all 8 authors...
AKI is characterized by increased catecholamine levels and hypertension. Renalase, a secretory flavoprotein that oxidizes catecholamines, attenuates ischemic injury and the associated increase in catecholamine levels in mice. However, whether the amine oxidase activity of renalase is involved in preventing ischemic injury is debated. In this study, recombinant renalase protected human proximal tubular (HK-2) cells against cisplatin- and hydrogen peroxide–induced necrosis. Similarly, genetic depl...
42 CitationsSource
#1Gary V. Desir (Yale University)H-Index: 29
#2Aldo J. Peixoto (Yale University)H-Index: 23
Abstract Renalase, a recently discovered flavoprotein, which is strongly expressed in the kidney and heart, effectively metabolizes catecholamines. It was discovered during the search to identify proteins secreted by the kidney that could help explain the high incidence of cardiovascular disease in patients with chronic kidney disease. Recent advances have led to more detailed knowledge of its biology, structure, enzymatic activity, mechanisms of action, associations with human disease states an...
52 CitationsSource
#1E. BrandH-Index: 31
#2Hermann PavenstädtH-Index: 48
Last. Holger ReineckeH-Index: 30
view all 9 authors...
Background During the past 10 years, chronic kidney disease (CKD) has been recognized as a major global health problem. Factors leading to decreased renal function are closely related to cardiovascular disease and vice versa. Cardiovascular morbidity and mortality are substantially increased in patients with CKD, even in those with only mild or moderate renal impairment. A better understanding of pathogenesis, risk factors, and genetic conditions is strongly required for more specific treatment ...
6 CitationsSource
#1Matthias Olden (NIH: National Institutes of Health)H-Index: 4
#2Alexander Teumer (University of Greifswald)H-Index: 70
Last. Conall M. O'Seaghdha (Harvard University)H-Index: 21
view all 27 authors...
Background Chronic kidney disease is associated with cardiovascular disease. We tested for evidence of a shared genetic basis to these traits. Study Design We conducted 2 targeted analyses. First, we examined whether known single-nucleotide polymorphisms (SNPs) underpinning kidney traits were associated with a series of vascular phenotypes. Additionally, we tested whether vascular SNPs were associated with markers of kidney damage. Significance was set to 1.5×10 −4 (0.05/325 tests). Setting & Pa...
26 CitationsSource
Cited By0
#1Salim S. ViraniH-Index: 6
#2Alvaro AlonsoH-Index: 62
Last. Francesca N. DellingH-Index: 13
view all 41 authors...
Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovas...
3 CitationsSource